PerkinElmer to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 31, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, today announced that it will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 6, 2008, at 4:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.

Robert F. Friel, President and CEO, will provide an overview of the Company and its growth strategy.

To hear a live webcast of the presentation, visit the Investor Relations page on the Company's Web site at http://www.perkinelmer.com. A replay of the webcast will be available for two weeks.

PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.8 billion in 2007, has 9,100 employees serving customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through http://www.perkinelmer.com or 1-877-PKI-NYSE.